Symposium on Challenging Behavior in CHARGE Syndrome

电荷综合症挑战行为研讨会

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Symposium on Challenging Behaviors in CHARGE Syndrome will take place as a component of the Sixth International CHARGE Syndrome Conference to be held in Cleveland, Ohio, on July 25-27, 2003. CHARGE syndrome refers to children with a specific set of birth defects. "CHARGE" originally came from the first letter of some of the most common features seen in these children: coloboma, heart defect, atresia of the choanae, retardation of growth and development, genital and urinary abnormality, and ear abnormality and/or hearing loss. The diagnosis of CHARGE is based on finding several of these and possibly other features in a child. CHARGE was first identified in 1979, and more has been learned about its development over time. One issue that has been of considerable concern to parents is the development of severe behavior problems. Many children with CHARGE are also diagnosed with autism, attention deficit disorder, obsessive-compulsive disorder, as well as tic disorder. The Conference will bring together medical and educational personnel along with parents and families of children with CHARGE. The purpose of the symposium, for which funding is sought, is to bring together leading researchers in the behavioral components of CHARGE. There are four goals: 1) to share research and clinical findings regarding the behaviors of children with CHARGE in order to identify what is known, what is being studied, and what needs to be studied; 2) to develop and facilitate collaboration in the research on behavior problems in CHARGE; 3) to discuss and debate the behavioral phenotype issues of diagnosis, etiology, prevalence, and description of behavior problems based on research; and 4) to suggest current and future research needs.
描述(由申请人提供):CHARGE综合征中的肥胖行为研讨会将作为第六届国际CHARGE综合征会议的一部分于2003年7月25日至27日在俄亥俄州克利夫兰举行。 CHARGE综合征是指患有一组特定出生缺陷的儿童。“CHARGE”最初来自这些儿童中最常见的一些特征的第一个字母:缺损,心脏缺陷,闭锁的choorhea,生长发育迟缓,生殖器和泌尿系统异常,耳朵异常和/或听力损失。 CHARGE的诊断是基于在儿童中发现这些特征中的几个以及可能的其他特征。 CHARGE于1979年首次被发现,随着时间的推移,人们对它的发展有了更多的了解。 父母相当关注的一个问题是严重行为问题的发展。 许多患有CHARGE的儿童也被诊断患有自闭症、注意力缺陷障碍、强迫症和抽动障碍。 会议将汇集医疗和教育人员沿着与家长和家庭的儿童与收费。 研讨会的目的,为寻求资金,是汇集在充电的行为组成部分的领先研究人员。 有四个目标:1)分享关于儿童行为的研究和临床发现,以确定什么是已知的,什么是正在研究的,什么是需要研究的; 2)发展和促进合作,在行为问题的研究在CHARGE; 3)讨论和辩论的行为表型问题的诊断,病因,患病率,并根据研究行为问题的描述;(4)提出当前和未来的研究需求。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY SCOTFORD HARTSHORNE其他文献

TIMOTHY SCOTFORD HARTSHORNE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

The pathogenesis of ALG14-congenital disorders of glycosylation.
ALG14-先天性糖基化障碍的发病机制。
  • 批准号:
    23K14967
  • 财政年份:
    2023
  • 资助金额:
    $ 0.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identifying New Therapeutics and Molecular Mechanisms in Congenital Disorders of Glycosylation.
确定先天性糖基化疾病的新疗法和分子机制。
  • 批准号:
    10644811
  • 财政年份:
    2023
  • 资助金额:
    $ 0.3万
  • 项目类别:
Investigating the Genotype-Phenotype Relationships that Underlie Congenital Disorders with Cardiovascular Symptoms through Population-scale Analyses
通过人群规模分析研究具有心血管症状的先天性疾病背后的基因型-表型关系
  • 批准号:
    10724185
  • 财政年份:
    2023
  • 资助金额:
    $ 0.3万
  • 项目类别:
Identifying understudied protein-related glycoproteome disruption in Congenital Disorders of Glycosylation
识别先天性糖基化障碍中尚未研究的蛋白质相关糖蛋白组破坏
  • 批准号:
    10725869
  • 财政年份:
    2023
  • 资助金额:
    $ 0.3万
  • 项目类别:
Pathogenic Mechanisms of Congenital Disorders of Glycosylation
先天性糖基化障碍的发病机制
  • 批准号:
    10633548
  • 财政年份:
    2023
  • 资助金额:
    $ 0.3万
  • 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
  • 批准号:
    10480649
  • 财政年份:
    2022
  • 资助金额:
    $ 0.3万
  • 项目类别:
Assessment of a potential application of endogenous stem cells to treat congenital disorders
评估内源干细胞治疗先天性疾病的潜在应用
  • 批准号:
    22K20740
  • 财政年份:
    2022
  • 资助金额:
    $ 0.3万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
  • 批准号:
    10616658
  • 财政年份:
    2022
  • 资助金额:
    $ 0.3万
  • 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
  • 批准号:
    10040788
  • 财政年份:
    2020
  • 资助金额:
    $ 0.3万
  • 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
  • 批准号:
    10250486
  • 财政年份:
    2020
  • 资助金额:
    $ 0.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了